HomeIndustriesBiotechnology

Biotechnology

Avidity Biosciences Announces Phase 1/2 EXPLORE44 Trial of AOC 1044 for Duchenne Muscular Dystrophy Mutations

Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates announced the Phase 1/2 EXPLORE44™...

WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody

WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), and Toregem BioPharma, a biotech startup company from Kyoto University, announced that...

Plexision completes development of PlexAPR™, a rapid blood test to predict transplant rejection

Plexision, a biotechnology company, which provides personalized diagnostic testing services for organ transplant patients has completed development of a six-hour blood test to predict...

Cloud Automation is Speeding Up Innovation in Pharma and Life Sciences

In recent years, the life sciences and pharma industries have experienced an increase in regulatory oversight while also facing pressure to respond to global...

Avirmax Inc. Announces Issuance of U.S. Patent Covering Catalysis

Avirmax Inc., a company focused on delivering protein therapeutics via recombinant adeno-associated viral (rAAV) vectors announced that the United States Patent and Trademark Office...
0FansLike
0FollowersFollow
spot_img

Hot Topics